Clinical Trials List
2023-03-02 - 2023-02-09
Phase III
Not yet recruiting4
ICD-10C78.00
Secondary malignant neoplasm of unspecified lung
ICD-10C78.01
Secondary malignant neoplasm of right lung
ICD-10C78.02
Secondary malignant neoplasm of left lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.0
Secondary malignant neoplasm of lung
-
Trial Applicant
GILEAD SCIENCES HONG KONG LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 廖偉志 無
- 陳鴻仁 無
- Chih-Yen Tu 無
- Chen Chia-Hung 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳教恩 無
- Ping-Chih Hsu 無
- Chien-Ying Liu 無
- Chih-Liang Wang 無
- 柯皓文 無
- 黃宗楨 無
- 枋岳甫 無
- Chih-Hsi Kuo 無
- 林定佑 無
- Chih-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 莊政皓 無
- Inn-Wen Chong 無
- 李玫萱 無
- Ying-Ming Tsai Tsai 無
- 郭家佑 無
- KUAN-LI WU 無
- Chih-Jen Yang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
520 participants
